U.S. Water Utilities Stock News

In late 2025, Recursion Pharmaceuticals reported strong Phase 1b/2 TUPELO trial data for its MEK 1/2 inhibitor REC-4881 in familial adenomatous polyposis, followed by management’s participation in major healthcare conferences and increased attention from Wall Street analysts. The combination of positive REC-4881 efficacy signals and growing institutional interest has sharpened focus on Recursion’s AI-enabled drug discovery model as a potential value driver. We’ll now examine how the...

If you are wondering whether Valero Energy is priced fairly after its strong run, this article will walk through what the current market price might be implying about the company. The stock recently closed at US$178.27, with returns of 8.1% over the last 7 days, 2.4% over 30 days, 7.8% year to date, 48.3% over 1 year and 48.1% over 3 years, and a very large 5 year return of 259.4%. These moves have kept Valero Energy on the radar for investors who follow large US refiners and energy names...

Event context and recent stock performance Tango Therapeutics (TNGX) has been attracting fresh attention after a period of strong longer term share performance, with the stock showing a total return close to 179% over the past year. See our latest analysis for Tango Therapeutics. The recent 8.5% 1 day and 12.1% 7 day share price returns, alongside a 39.9% 90 day share price return, sit against a 178.7% 1 year total shareholder return. This suggests momentum has been building over time. If...

Event context and why BXP is on investors’ radar BXP (BXP) is back in focus after its recent share move, with the stock last closing at $68.10, which is putting fresh attention on how its returns and fundamentals stack up today. See our latest analysis for BXP. BXP’s recent 1 day share price return of 1.51% comes after a softer patch, with the 90 day share price return of 6.75% decline contrasting with a 3 year total shareholder return of 20.12%. This suggests that longer term holders have...

In recent days, Grand Canyon Education increased its stock repurchase authorization by US$300 million to US$2.55 billion and Grand Canyon University secured formal recognition of its non-profit status from the U.S. Department of Education, resolving a longstanding dispute. This combination of an enlarged buyback pool and clarified non-profit status could reshape how investors assess the company’s capital allocation and growth avenues tied to scholarships, grants, and partnerships. Next,...

Cadence Design Systems (CDNS) has launched a Chiplet Spec-to-Packaged Parts ecosystem focused on physical AI, data center, and high performance computing, in partnership with Arm, Samsung Foundry, and several IP providers. See our latest analysis for Cadence Design Systems. The Chiplet Spec-to-Packaged Parts launch lands after a softer 90-day share price return of 10.10% and a 30-day share price return decline of 6.78%, while the 3-year total shareholder return of 91.48% and 5-year total...

If you are wondering whether Travelers Companies at US$285.19 is still reasonably priced or starting to look expensive, you are in the right place to unpack what the current share price might be implying. The stock has had a mixed recent run, with a 2.5% decline over the last 7 days, a 1.5% return over 30 days, and a 19.9% return over the past year. The 3 year and 5 year returns sit at 57.9% and 124.6% respectively. Alongside these moves, investors have been reacting to ongoing sector wide...

Earlier this week, PayPal launched its Transaction Graph Insights & Measurement program, using data from over 430 million consumer accounts and tens of millions of merchants to give brands a cross-merchant view of real shopper behavior and advertising performance. The new suite positions PayPal as an insights provider as well as a payments platform, turning its transaction graph into a tool for merchants to identify high-intent shoppers and quantify true sales lift rather than modeled...

As the U.S. stock market experiences mixed movements, with major indices like the Dow Jones and S&P 500 setting fresh all-time highs, investors are navigating a landscape marked by geopolitical developments and fluctuating oil prices. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential investment opportunities for those looking to capitalize on market inefficiencies amidst these dynamic conditions.

As the U.S. stock market experiences mixed movements with the Dow Jones and S&P 500 reaching fresh all-time highs, investors are keeping a close eye on geopolitical developments and economic indicators such as employment data. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best and may offer resilience amid market fluctuations.

Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...

As the Dow Jones and S&P 500 reach new all-time highs, the U.S. stock market continues to capture investors' attention amidst mixed economic signals, including a weakening labor market and geopolitical developments. In this dynamic environment, identifying promising small-cap stocks can offer valuable opportunities for growth, particularly when these companies demonstrate resilience and potential in sectors poised for expansion.

If you are trying to work out whether CRISPR Therapeutics is priced attractively right now, it helps to first line up what the recent share moves and current valuation are really telling you. The stock last closed at US$58.19, with returns of 9.4% over the past week, 2.3% over the past month, 8.2% year to date, 38.8% over the past year and 20.6% over three years, while the five year return sits at a 69.4% decline. Recent attention on CRISPR Therapeutics has been shaped by news around its...

General Dynamics (GD) has drawn fresh attention as investors reassess major defense and aerospace names, with the stock recently closing at $360.71 after a year that included double digit total returns. See our latest analysis for General Dynamics. The recent move in General Dynamics' share price, including a 6.9% 1 month share price return and a 5.0% year to date share price return, sits alongside a 41.8% 1 year total shareholder return and 162.8% 5 year total shareholder return. This points...

In its most recent quarter, Chewy reported US$3.12 billion in revenue, an 8.3% year-on-year increase that modestly exceeded analyst expectations and was accompanied by stronger-than-expected EBITDA performance. Shortly after these results, Viking Global Investors lifted its Chewy stake by very large double digits, highlighting strong institutional conviction in the company’s underlying business strength despite earlier pressure on the shares. Next, we’ll examine how Viking Global’s larger...

SouthState Bank (SSB) shares have been drawing attention after recent trading, with the stock last closing at $97.12. Investors are weighing this price against the bank’s earnings profile and overall return history. See our latest analysis for SouthState Bank. The recent 1-day share price return of 1.64% and 1-month share price return of 5.40% suggest some momentum is building, even though the 3.07% year to date share price return and 3.57% 1-year total shareholder return remain relatively...

Dole (NYSE:DOLE) has recently drawn attention after a mixed run in the stock, with a decline over the past month but a gain over the past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Dole. Over the past year, Dole’s share price has had a softer year to date but a stronger 90 day run, while its 1 year and 3 year total shareholder returns point to more supportive longer term momentum. If Dole’s recent moves have you rethinking your watchlist,...

In recent months, Medpace Holdings has been consolidating near its 52-week high after a strong multi-month rally, while announcing that it will report its fourth quarter and fiscal year 2025 results on 9 February 2026, followed by a conference call on 10 February 2026. This period has highlighted continued optimism around Medpace’s leadership in complex outsourced clinical research and disciplined margin management, reinforced by generally constructive analyst views despite some valuation...

Delcath Systems (DCTH) is back in focus after publishing detailed subgroup analyses from its phase 3 FOCUS study on HEPZATO KIT in unresectable metastatic uveal melanoma, helping refine how clinicians view efficacy and safety across different patient groups. See our latest analysis for Delcath Systems. The publication arrives after a mixed stretch for Delcath Systems, with a 30 day share price return of 6.85% and a 90 day share price return decline of 5.86%. The 3 year total shareholder...

If you are asking whether Halozyme Therapeutics at around US$73.13 is still priced attractively, you are exactly who this breakdown is for. The stock has logged returns of 8.0% over the last week, 15.5% over the last month, and 42.9% over the past year, which naturally raises questions about growth potential and how much risk is now priced in. Recent coverage has focused on Halozyme Therapeutics as a US biotechnology company listed on the NASDAQ, with evergreen investor interest in how its...

Piper Sandler’s decision to cut Twilio (TWLO) to a Neutral rating after two years of a more positive stance, citing valuation and potential growth slowdown by 2026, has sharpened investor focus on the stock. See our latest analysis for Twilio. Recent trading reflects mixed momentum, with a 22.21% 3 month share price return and a 26.92% 1 year total shareholder return, even as the latest downgrade and debate around Twilio’s growth outlook have tempered some of the earlier enthusiasm. If...

Why Firefly Aerospace is Suddenly in the Spotlight Firefly Aerospace (FLY) has drawn intense attention after multiple law firms announced class action lawsuits alleging misleading disclosures around demand for its Spacecraft Solutions and the readiness of its Alpha rocket program. The complaints center on statements tied to Firefly's August 2025 IPO and subsequent disclosures, following disappointing financial results and an Alpha Flight 7 mission issue that coincided with sharp share price...

Tenable Holdings recently announced a partnership with cybersecurity distributor Distology, adding its exposure management platform to Distology’s portfolio for channel partners across the UK, Europe, the Middle East, and Africa to help organizations assess and prioritize security risks across IT, cloud, and operational environments. This collaboration highlights how distributors are becoming central in getting unified exposure management tools into more regional markets, potentially...

Southwest Airlines (LUV) shares have been getting attention after recent performance metrics showed a 12.2% move over the past month and a 30.9% gain in the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Southwest Airlines. That recent 30.9% 3 month share price return comes on top of a 1 year total shareholder return of 32%. This suggests momentum has picked up again after a quieter year to date and refocuses attention on whether the current US$42.48...